In cholangiocarcinoma (CCA) cells, magnolol significantly inhibits cell growth, migration, and invasion, accompanied by decreased expression of Ki67, proliferating cell nuclear antigen (PCNA), matrix metalloproteinases 2 (MMP-2), MMP-7, and MMP-9. Here, MMP2 is linked to cholangiocarcinoma.